Log in to save to my catalogue

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_886696134

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

About this item

Full title

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

Publisher

London: Informa Healthcare

Journal title

Expert review of anticancer therapy, 2011-08, Vol.11 (8), p.1303-1313

Language

English

Formats

Publication information

Publisher

London: Informa Healthcare

More information

Scope and Contents

Contents

Neutropenia is a frequent complication of anticancer chemotherapy (CT) often associated with life-threatening infections, hospitalization, dose reduction and/or delay in the administration of CT. Administration of recombinant granulocyte colony-stimulating factor (rG-CSF) reduces the duration and the degree of CT-neutropenia. rG-CSF that stimulates...

Alternative Titles

Full title

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_886696134

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_886696134

Other Identifiers

ISSN

1473-7140

E-ISSN

1744-8328

DOI

10.1586/era.11.72

How to access this item